Has M Ismail, MD received payments from drug or device companies?

Yes. Drug and device makers reported $41,522 in general payments to M Ismail, MD across 82 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean M Ismail, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about M Ismail, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

M Ismail, MD

Psychiatry · Rochester, NYNPI 1346278603

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $32,556 of the $41,522 with a category attached, or 78.4%. 6 manufacturers reported payments, led by Neurocrine Biosciences, Inc. at 53.3% of the total. Reporting peaked in 2019 at $20,916 and has fallen 99.8% since, to $33 in 2025. Among psychiatry clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$41,522in general payments, 2019–2025

Across 82 payments — averaging $506.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Neurocrine Biosciences, Inc.$22K
Johnson & Johnson$19K
AbbVie$166
Biogen$77
Teva Pharmaceuticals USA, Inc.$36
Otsuka America Pharmaceutical, Inc.$16

$700,419in research payments, 2019–2025

Across 104 payments — averaging $6734.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Janssen Research & Development, LLC$206K
Johnson & Johnson$180K
Biontech SE$151K
Jazz Pharmaceuticals Inc.$68K
Eisai Inc.$44K
Novartis$27K
plus $24K from 2 others

What the payments were for

Consulting fees$4,09610%
Speaking & faculty fees$32,55678%
Travel & lodging$3,3428%
Food & beverage$1,5284%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Neurocrine Biosciences, Inc.	38	$22,148
Johnson & Johnson	30	$19,079
AbbVie	10	$166
Biogen	1	$77
Teva Pharmaceuticals USA, Inc.	2	$36
Otsuka America Pharmaceutical, Inc.	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$41,522 in reported general payments places this provider in the 95th percentile of 3,713 psychiatry providers in New York.

See all psychiatry providers in New York →

Medicare billing

Part B allowed, 2024

$2,049

Medicare patients

Services billed

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Paliperidone ErPaliperidone	17	$5,121
Clozapine	50	$4,058
Olanzapine	93	$1,326
Bupropion XlBupropion Hcl	59	$857
Trifluoperazine Hcl	26	$827
Oxcarbazepine	13	$547
Quetiapine Fumarate	54	$460
Lithium Carbonate	43	$433
Carbamazepine	12	$410
Divalproex Sodium ErDivalproex Sodium	30	$382
Hydroxyzine Pamoate	29	$339
Buspirone Hcl	27	$305
Risperidone	25	$272
Venlafaxine Hcl ErVenlafaxine Hcl	14	$220
Trazodone Hcl	43	$215

Paid to pharmacies, not to this prescriber.

Other psychiatry in Rochester

Tulio OrtegaRochester$319K
Anton PorsteinssonRochester$295K
Leslie CitromePomona$5.7M
Sanjay GuptaCheektowaga$1.9M
Richard PriceMonsey$1.7M
Adam AshtonAmherst$1.6M
Christoph CorrellGlen Oaks$1.5M
Manish ZinzuvadiaNew York$1.3M
George KruseBronx$1.2M
Jianping ChenNew York$1.2M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →